News blog

Akers Biosciences Inc

  • BY: Andrew Hore |
  • POSTED: 19/07/2013 |

Diagnostics products developed Akers Biosciences Inc says that its interim figures are ahead of expectations. 

Akers has delivered 4.9m disposable breath alcohol detectors to distributor Chubeworkx Guernsey. This is before the North American distribution agreement has contributed to sales. There has also been a small increase in sales of PIFA Heparin/PF4 rapid assays.

Daniel Stewart is maintaining is 2013 profit forecast at $500,000 on trebled revenues of $4.5m but if the business continues to progress at this rate then there could be an upgrade later in the year.

At 1.23p a share, up 0.18p, Akers is valued at £2.93m.

Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFJuly2013_46.pdf

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds